Evidence map›Paper›PMID 40783683›Full record

ArticleBiological procedures online2025

A Rare Case of Long-Term Survival in Stage IIIB Lung Adenocarcinoma: an 9-Year Follow-Up.

Jianing Chen, Li Liu, Qi Wang, Yan Wu, Jing Zhao, Li Wang, Lei Cheng, Huiming Zhu, Chunxia Su

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biological procedures online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jianing Chen *Department of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China.
Li Liu *Department of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China.
Qi WangDepartment of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China.
Yan WuDepartment of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China.
Jing ZhaoDepartment of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China.
Li WangDepartment of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China.
Lei ChengDepartment of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Shanghai, China.
Huiming ZhuDepartment of Ultrasound, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Chunxia SuDepartment of Medicial Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China. susu_mail@126.com.

Funding

National Key R&D Program of China 2023YFC2508604Tongji University Medicine-X Interdisciplinary Research Initiative TJ-FK-YXJC008
6 · The paper itself

Abstract

We report a rare case of long-term survival in a 59-year-old male patient diagnosed with stage IIIB lung adenocarcinoma. Despite disease progression following initial chemotherapy, the patient achieved prolonged survival through a combination of chemotherapy and radiotherapy. This case highlights the potential for extended survival in advanced lung cancer with multimodal treatment approaches.

Indexed as

ChemotherapyLong-term SurvivalLung AdenocarcinomaRadiotherapyStage IIIB

Identifiers

PMID40783683
PMCPMC12335796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.